>

Publications and resources

>

Publications

Read the latest highlights that cover news and updates about the plasma and blood industry. Stay up to date with the events where stakeholders, members, and patients get together and discuss key developments and issues by taking a look at our available publications.

3d shape in blue, customized according to PPTA's branding

3d shape in blue, customized according to PPTA's branding

3d shape in blue, customized according to PPTA's branding

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

PPTA Europe needs to collect more plasma

PPTA Position Paper (2019)

This is some text inside of a div block.

This is some text inside of a div block.

PPTA Europe needs to collect more plasma

PPTA Position Paper (2019)

This is some text inside of a div block.

Commission staff working document on the implementation of the principle of voluntary and unpaid donation

For human blood and blood components as foreseen in Directive 2002/98/EC on setting standards of quality and safety for the collection, testing, processing, storage, and distribution of human blood and blood components and amending Directive 2001/83/EC.

This is some text inside of a div block.

This is some text inside of a div block.

Commission staff working document on the implementation of the principle of voluntary and unpaid donation

For human blood and blood components as foreseen in Directive 2002/98/EC on setting standards of quality and safety for the collection, testing, processing, storage, and distribution of human blood and blood components and amending Directive 2001/83/EC.

This is some text inside of a div block.

Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA

Plasma for the manufacturing of medicinal products is considered to be an essential Substance of Human Origin

This is some text inside of a div block.

This is some text inside of a div block.

Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA

Plasma for the manufacturing of medicinal products is considered to be an essential Substance of Human Origin

This is some text inside of a div block.

Key Economic and Value Considerations for Plasma-derived Medicinal Products (PDMPs) in Europe

Kluszczynski, Rohr & Ernst (2020). Vintura White Paper.

This is some text inside of a div block.

This is some text inside of a div block.

Key Economic and Value Considerations for Plasma-derived Medicinal Products (PDMPs) in Europe

Kluszczynski, Rohr & Ernst (2020). Vintura White Paper.

This is some text inside of a div block.